๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Variability of tumor response to chemotherapy I. Contribution of host heterogeneity

โœ Scribed by L. Simpson-Herren; P. E. Noker; S. D. Wagoner


Publisher
Springer
Year
1987
Tongue
English
Weight
874 KB
Volume
20
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Molecular markers predictive of response
โœ Vincenzo Catalano; Anna Maria Baldelli; Paolo Giordani; Stefano Cascinu ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 119 KB

Gastrointestinal cancers account for a large amount of human tumors. Surgery is the standard treatment for localized gastrointestinal cancer, but in a large number of patients, tumors are unresectable at time of diagnosis and even when resectable, survival is often poor. Current attempts to improve

The effect of elevated levels of thrombo
โœ J. Paul Waymack; Gabriel Fernandes; Jaya Venkatraman; Eliezer Flescher; Roger W. ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 679 KB

Previous studies have demonstrated that human malignancies can synthesize large amounts of thromboxane. It has also been reported that thromboxane can significantly alter multiple components of physiologic and immunologic function. We investigated the effect of elevated levels of thromboxane on host

Effect of insulin-like growth factor 1 o
โœ Yuan-Lin Dong; R. Y. Declan Fleming; K. Fon Huang; David N. Herndon; Tina Z. Yan ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 579 KB

Oncology patients suffer multiple detrimental metabolic alterations. Among these are catabolism of tumor free body mass to supply nutrients to feed the tumor. This results not only in enhanced tumor growth but also poor wound healing and immunosuppression of the tumor host. Efforts are therefore bei